Scientific title: Closed-loop in sub-optimally controlled type 1 diabetes under free-living conditions (APCam11)
Principal Investigator: Dr Roman Hovorka
Institution: University of Cambridge
Project duration: 01/09/2014 – 31/07/2018
Objective: Dr Hovorka is aiming to determine whether using artificial pancreas technology with a threshold-based pump interruption feature can improve glucose control and reduce the risk of hypoglycaemia in youth and adults.
Previous, smaller studies have shown that use of artificial pancreas technology in youth and adults is safe, improves glucose control and reduces the risk of hypoglycaemia overnight.
This current study will now test the technology for a longer period of time – 3 months – and with more participants. The youth group will consist of 40 participants between 6 to 21 years old, and the adult group will consist of 40 participants over 22 years old.
Categories: Treat, Artificial pancreas, Hypoglycaemia